报价延迟最少15分钟:2025/08/25 10:35 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
4.725 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-1.81/-1.88
|
|
企业价值
257.05M
|
| 资产负债 |
|
每股账面净值
6.29
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
135.44M
|
|
每股收益
2.49
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
报价延迟最少15分钟：2025/08/25 10:35 EDT
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platformsdesigned by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific. |
